Suspend intellectual property rights for covid-19 vaccines
Authors:
- Priti KrishtelPKPriti Krishtel
- Rohit MalpaniRMRohit Malpani
Abstract
Waivers are essential for global vaccine equityKeywords
This publication has 4 references indexed in Scilit:
- Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectivesVaccine: X, 2020
- Manufacturing costs of HPV vaccines for developing countriesVaccine, 2016
- Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturersVaccine, 2015
- Indian vaccine innovation: the case of Shantha BiotechnicsGlobalization and Health, 2011